These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Attenuation of iminodipropionitrile induced behavioral syndrome by sodium salicylate in rats. Tariq M; Khan HA; Al Moutaery K; Al Deeb S Pharmacol Biochem Behav; 2002 Oct; 73(3):647-54. PubMed ID: 12151040 [TBL] [Abstract][Full Text] [Related]
8. Sodium benzoate attenuates iminodipropionitrile-induced behavioral syndrome in rats. Tariq M; Khan HA; Al Moutaery K; Al Deeb S Behav Pharmacol; 2004 Dec; 15(8):585-8. PubMed ID: 15577457 [TBL] [Abstract][Full Text] [Related]
9. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. Ogawa N; Mizukawa K; Haba K; Sato H Eur Neurol; 1990; 30 Suppl 1():31-40. PubMed ID: 1968833 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. Zhou LW; Qin ZH; Weiss B Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250 [TBL] [Abstract][Full Text] [Related]
11. Protection by 2-deoxy-D-glucose against beta,beta'-iminodipropionitrile-induced neurobehavioral toxicity in mice. Tariq M; Khan HA; al Moutaery K; al Deeb S Exp Neurol; 1999 Jul; 158(1):229-33. PubMed ID: 10448436 [TBL] [Abstract][Full Text] [Related]
12. The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine. Cadet JL; Taylor E; Freed WJ Pharmacol Biochem Behav; 1988 Feb; 29(2):381-5. PubMed ID: 2452450 [TBL] [Abstract][Full Text] [Related]
14. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity. Helmeste DM Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413 [TBL] [Abstract][Full Text] [Related]
15. Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat. Langlais PJ; Huang PC; Gabay S J Neurosci Res; 1975; 1(5-6):419-35. PubMed ID: 1241588 [TBL] [Abstract][Full Text] [Related]
16. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway. Mandel RJ; Yurek DM; Randall PK Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002 [TBL] [Abstract][Full Text] [Related]
17. Comparison of location, severity, and dose response of proximal axonal lesions induced by 3,3'-iminodipropionitrile and deuterium substituted analogs. Denlinger RH; Anthony DC; Amarnath V; Graham DG J Neuropathol Exp Neurol; 1992 Nov; 51(6):569-76. PubMed ID: 1484287 [TBL] [Abstract][Full Text] [Related]
18. Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3'-iminodipropionitrile in male rats. Nace CG; Genter MB; Sayre LM; Crofton KM Fundam Appl Toxicol; 1997 Jun; 37(2):131-40. PubMed ID: 9242586 [TBL] [Abstract][Full Text] [Related]
20. Development of degenerative muscle weakness by chronic administration of beta,beta'-iminodipropionitrile in the drinking water to rats: a model for motorneuropathy. Kitahara Y; Maki T; Torii K Physiol Behav; 1997 Sep; 62(3):443-51. PubMed ID: 9272649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]